Protein Biomarkers Predictive of Multivalent Response to a Novel Dengue Vaccine

Back to the list Next article Previous article

June 9, 2018

V. Hindie¹, P. Croteau¹, S. Aziri¹, S. Lo¹, J. Sui¹, L. Cortes¹, E. Kallas², R.P. Sekaly³, and E. Paramithiotis¹. ¹Caprion Biosciences Inc, Montreal, QC, Canada. ²School of Medicine, University of Sao Paulo, Sao Paulo, Brazil. ³Case Western Reserve University, Cleveland, OH, USA. VH, PC, SA, SL, JS, LC, and EP are employees of Caprion Biosciences Inc.

Protein Biomarkers Predictive of Multivalent Response to a Novel Dengue Vaccine, European Congress of Immunology, 2018